Pharmaceutical Equivalent Study of Vildagliptin Formulation.

Safila Naveed; Fatima Qamar; Hina Rehman; Syeda Zainab; Syeda Sarah Abbas; Khan Usmanghani; Ghulam Sarwar; Mohammad Tanweer Alam

The aim of this study is to check pharmaceutical equivalence of different brands of vildagliptin tablets available in Karachi, Pakistan. Two different brands of vildagliptin tablets were investigated in the study. Four quality control (QC) parameters: weight variation, Diameter test, thickness, disintegration and dissolution test were carried out specified by BP/USP (British and United States pharmacopeia). The results of the study revealed that the parameters such as weight variation, Diameter test, thickness, disintegration test are in accordance with BP/USP limits.

ChantalMathieu, .Evy Degrande Vildagliptin: a new oral treatment for type 2 diabetes mellitus Vasc Health Risk Manag,2008 Dec; 4 1349 -1360

CorneliaB Landersdorfer,Yan-Ling He,William J Jusko, 2012.Mechanism-based population pharmacokinetic modelling in diabetes: vildagliptin as a tight binding inhibitor and substrate of dipeptidyl peptidase IV Br J Clin Pharmacol, 73 391 -401

KeatingGM, 2010.Vildagliptin: a review of its use in type 2 diabetes mellitus,Drugs 70 2089 -2112

FonsecaV,BaronM,ShaoQ,DejagerS., 2008.Sustained efficacy and reduced hypoglycemia during one year of treatment with vildagliptin added to insulin in patients with type 2 diabetes mellitus,Horm Metab Res 40 427 -430

MatthewsDR,DejagerS,AhrenB, 2010.Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2 - y e a r s t u d y. D i a b e t e s O b e s M e t a b, 12 780 -789

AhrenB,FoleyJE,BosiE., 2011.Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin,Diabetes Obes Metab 13 193 -203

KleppingerEL,HelmsK., 2007.The role of vildagliptin in the management of type 2 diabetes mellitus,Ann Pharmacother 41 824 -32